Non-compliance has received significant attention in medicine, yet few studies have examined its correlates in autologous hematopoietic SCT (AHSCT) patients. This study examined predictors of non-compliance in a sample of 151 AHSCT patients treated in an outpatient setting. Before AHSCT, participants completed a validated measure of mood and retrospective chart reviews were conducted to assess non-compliance during AHSCT, defined as refusal of oral hygiene, prescribed exercise programs, oral nutrition and/or prescribed medications. We found 121 patients (80%) were non-compliant with an aspect of the AHSCT regimen on 1 or more days; mean percentage of noncompliant days was 16.6 (s.d. 15.6). Men were more likely than women to be non-compliant (Po0.05); as were participants with an elevated depression score (Po0.05).
Introduction
The use of autologous hematopoietic SCT (AHSCT) has steadily increased in the last 15 years. 1, 2 Medical and technological advances have led to improvements in supportive care, 3 and the procedure has safely moved to the outpatient setting for selected patients. 4 The treatment regimen is complex, and requires the patient to engage in numerous self-care activities, such as taking medications in a timely manner, following dietary restrictions, meeting caloric goals, performing oral care, exercising, and avoiding crowds and people with infections. Research has focused on the importance of supportive care in ensuring the health of populations previously thought unable to tolerate AHSCT, including those over 60, 5 patients receiving acute care in the home 6 and high-risk patients. 7, 8 Compliance is stressed by health professionals throughout the AHSCT process, and is particularly important for patients who receive the transplant as an outpatient, where care outside the treatment center is rendered by the patient and his or her caregiver independent of the health care team. 4 Limited research on compliance in AHSCT has been conducted. One report 9 found post transplant distress was associated with medication non-adherence in 80 patients who had received an autologous or allogeneic transplant. In another study of 120 allogeneic transplant patients, those ranked high on compliance with medical advice pretransplant were less likely to die in the hospital, had a shorter length of stay, faster engraftment of neutrophils and platelets, and were less likely to be readmitted. 10 The lack of research exploring the prevalence and predictors of non-compliance among patients undergoing AHSCT is surprising, 11, 12 given the degree of self-care expected and the amount of time transplant staff devote to providing education and guidance on the topic.
Compliance is defined as the extent to which a patient's behavior coincides with medical or health advice. 13 Significantly high non-compliance in preventative and curative situations have been documented in the medical literature, 14, 15 with adverse effects on health outcomes, morbidity and mortality. 16 Research in the solid organ transplant and cancer literature suggested that factors such as age, gender, treatment-related variables, psychological distress and social support predict non-compliance. [17] [18] [19] [20] [21] [22] On the basis of these findings, it was anticipated that similar non-compliance trends would be prevalent amongst patients undergoing AHSCT. This study is both exploratory and descriptive, and aimed to identify the prevalence and predictors of non-compliance in a group of AHSCT patients treated in an outpatient setting. Previous research at our center demonstrated 15-22% of patients report depressed mood before transplant, 23 therefore, it was proposed that patients with elevated levels of depression would be less compliant during AHSCT. The impact of sociodemographic and medical variables was also examined.
Materials and methods

Participants
Data from 151 consecutive adult patients who underwent outpatient AHSCT at a large Midwestern cancer center were used. Eligibility criteria for inclusion were a minimum age of 18 and an outpatient AHSCT transplant procedure. The study was approved by the institutional review board.
Procedure and measures
This study used data from several sources; before AHSCT, patients completed an investigator-derived clinic information form to obtain sociodemographics, data on social support and coping, and the Symptom-Checklist 90-Revised (SCL-90-R) to assess mood disturbance. Non-compliance during AHSCT was coded through a retrospective chart review (measures are described below).
Patient database. Before AHSCT, a demographic summary is recorded in the medical record including type of cancer, stage, remission status and time from diagnosis to transplant. Information is later updated with AHSCTrelated medical information (for example, number of days to engraftment, survival status).
Clinic information form. This form includes questions regarding marital status, education level, work status, social support, coping and previous mental health treatment.
Symptom-Checklist 90-Revised. The SCL-90-R is a self report inventory of 90 psychological symptoms of depression, anxiety, phobic anxiety, somatization, obsessivecompulsive, interpersonal sensitivity, hostility, paranoid ideation, psychoticism and global severity index (GSI). 24 Items are scored on a five-point scale from 'not at all' (0) to 'extremely' (4). The inventory has been widely used with medical and cancer patients. Internal consistency estimates range from 0.77 to 0.90 for the subscales. The depression subscale and GSI were a focus of this study. The depression subscale includes 13 items that reflect depressive symptoms; sad mood, tearfulness, hopelessness, worthlessness, changes in sleep and appetite, and decreased interest and pleasure in activities. The GSI is an average of all 90 items and reflects total overall distress. Using gender-specific normative data, scores are transformed into T-scores with a mean of 50 and s.d. of 10; scores of X63 suggest high levels of distress.
Charlson comorbidity index. The Charlson comorbidity index was developed to predict the risk of mortality from co-morbid illness within a 1-year period, and has been widely used and validated throughout the oncology literature. 25 Higher scores, based on risk of death, indicate greater severity of comorbid medical conditions. Non-compliance. Non-compliance was assessed through retrospective review of the medical record using the medical chart review form developed by the investigators. For each day of the hospitalization, all members of the health care team routinely record the patient's compliance and noncompliance behavior. Two research assistants rated on the medical chart review form whether non-compliance was noted in the patient's medical record. Examples of noncompliant behavior included (a) any reference to a patient being 'non-compliant' with required self-care activities (for example, oral care, hygiene), (b) refused medications, (c) patient refusal to perform required exercises to maintain muscle tone (d) or other self-care. The total number of days of non-compliance, as recorded in the medical record, and the total days of admission were recorded on the medical chart review form. Total days of non-compliance divided by total days of admission (that is, length of stay) yielded an overall non-compliance percentage score with higher percentages indicating greater degrees of non-compliance.
Physical morbidity. Physical morbidity data regarding the frequency and intensity of treatment related side effects was also retrieved through retrospective chart review. For each day of the transplant hospitalization, the intensity (1 ¼ mild, 2 ¼ moderate, 3 ¼ severe) was rated for (a) nausea and vomiting, (b) fever, (c) pain associated with mucositis and (d) diarrhea.
Inter-rater reliability. To assess inter-rater reliability on the medical chart review form, research assistants performed independent reviews of 10% of the medical records, at three time points using Cohen's k, which represents the extent to which agreement exceeds what would be expected by chance. 26 Kappa-coefficients at the beginning reliability check ranged from 0.83 to 1.00. Disagreements were resolved through discussion. Middle reliability kappacoefficients ranged from 0.85 to 1.00, and end reliability kappa-coefficients ranged from 0.83 to 1.00. Thus, acceptable agreement was established and maintained throughout coding. As acceptable kappa-coefficients were reached at each checkpoint, the remaining medical charts were coded separately by both the research assistants.
Statistics
All P-values reported are two-tailed, and statistical analyses were performed using the Predictive Analytics Software, version 17 (formerly SPSS-17.0; IBM North America, New York, NY, USA). Descriptive data are presented using means and medians for continuous variables and frequencies and percentages for categorical variables. Variables were standardized to Z-scores (M ¼ 0, s.d. ¼ 1). Comparisons among patients on sociodemographics, medical and psychological variables were made using independent samples t-tests. Zero-order correlations established significant associations between non-compliance, medical variables, sociodemographics (for example, age, gender, social support) and psychological. To determine significant predictors of non-compliance, stepwise multiple regression analyses 27 were performed with non-compliance percentage score as the dependent variable and significant zero-order correlations as independent variables: (a) gender, (b) total nausea and vomiting intensity; and from the SCL-90-R, (c) GSI (d) and depression subscale. A variable was entered into the model if the significance level of Po0.05 and was excluded if the significance level was P40.10. As this study was exploratory, we also examined interaction effects to see whether the predictive value of variables would change when their impact on each other was taken into account. On the basis of statistical recommendations, 21 stepwise multiple regression was chosen as an appropriate when research is predictive and exploratory.
Results
Inclusion criteria were met by 86 females and 65 males (see Table 1 for demographic and medical information). Overall, 121 patients (80%) were non-compliant with an aspect of the AHSCT treatment on 1 or more days. Zero-order correlations were computed for non-compliance and clinical, physical and psychosocial variables ( Table 2 ). Significant associations were found between non-compliance and gender, nausea and vomiting intensity, and mood.
SCL-90-R descriptives and the percent of participants scoring in the clinically significant range for mood disturbance (scores X63) are listed in Table 3 Stepwise multiple regression analyses were conducted to identify predictors of non-compliance; variables that significantly correlated with non-compliance in earlier analyses were included in the regression models. In the first regression model, the depressive subscale of the SCL-90-R predicted non-compliance (b ¼ 0.893, t ¼ 3.52, P ¼ 0.001) as did gender (b ¼ 1.03, t ¼ 2.44, P ¼ 0.016); however, the interaction of depression and gender was found to be more predictive (b ¼ À1.32, t ¼ À2.89, P ¼ 0.004). This model accounted for 10.6% of the explained variance within non-compliance, F(3, 146) ¼ 6.92, P ¼ 0.000 (Table 4) .
In the second regression model, the GSI of the SCL-90-R also predicted non-compliance (b ¼ 0.933, t ¼ 3.57, P ¼ 0.000). Again, although gender was a significant predictor in this model (b ¼ À0.179 t ¼ À2.30, P ¼ 0.023), the interaction of overall distress and gender was more predictive (b ¼ À0.793, t ¼ À3.04, P ¼ 0.003). This model accounted for 10.5% of the explained variance within non-compliance, F(3, 146) ¼ 6.84, P ¼ 0.000 (Table 5 ).
The negative b weight of the interaction terms in both these models indicate that the effects of depression and overall distress on non-compliance were greater for men than for women (Tables 4 and 5 ).
In the third regression model, nausea/vomiting symptoms during AHSCT significantly predicted non-compliance (b ¼ 0.236, t ¼ 2.87, P ¼ 0.005), accounting for 4.9% of the explained variance within non-compliance. Gender had previously been demonstrated to be non-significant with nausea/vomiting and did not increase significance in the regression.
Discussion
Non-compliance with medical advice is established as an important predictor of health outcomes, morbidity and mortality 16 for many medical specialties. 28 However, limited research has examined the same relationship in the BMT literature. This study is one of the first efforts to describe the prevalence and predictors of non-compliance in AHSCT recipients treated in the outpatient setting. The rate of patients' non-compliance with at least one of more aspect of routinely recommended care was high and individuals with increased levels of depression and distress and greater nausea and vomiting intensity were significantly more non-compliant than patients without such elevations. The relationship between depressed mood and poor compliance has been documented in the literature on solid organ transplantation and oncology, [17] [18] [19] [20] [21] and this study now extends this finding to the outpatient AHSCT population. To better understand the risk factors associated with non-compliance, we computed interaction variables of gender with both depression and distress scores. Alone each of these variables was related to overall non-compliance and further analysis revealed that the interaction of the psychological variables with gender was an even more robust predictor of non-compliance.
As suggested by DiMatteo et al. 22 depressed mood can impact compliance for a variety of reasons. First, depressed mood is usually accompanied by feelings of hopelessness and despair, which can negatively impact the individual's sense of optimism that compliance with treatment regimens will have a positive impact on short-or long-term outcomes. In addition, a depressed medical patient may have fewer supportive others to encourage him or her to be compliant. However, this is less likely to be an issue in outpatient AHSCT because patients are required to have a support system and an identified caregiver. Although not examined in this study, it may be that the patient's support system experiences caregiver strain that negatively impacts on the frequency and/or quality of encouragement. Another unstudied factor in the outpatient setting is the possibility of diffusion of responsibility between the health care team and the patient's caregiver for promoting compliance. Finally, cognitive changes and fatigue associated with both depression and the side effects of transplant may affect the patient's compliance. With regard to gender, men in our study showed higher levels of non-compliance than women, which is similar to gender trends seen in oncology and solid organ transplantation studies. [29] [30] [31] Additional studies have shown that men engage in riskier health behaviors and hold riskier health beliefs, which could potentially contribute to poorer compliance. 32 An interesting finding to emerge from this study was that men reported higher rates of depressed mood than women. Although this difference did not reach statistical significance, it is surprising considering that studies typically report women have a prevalence rate for depression up to twice that of men. [33] [34] [35] It is possible that fatigue and the need for isolation during AHSCT limits the coping tools of men more than women, as men often cope with depressed mood through the use of externally focused techniques, such as engaging in activities. 36 Also, isolation during the AHSCT may uniquely affect men as they may be less likely to share their depressed thoughts with the health care team or visiting family and friends, 37 and thus could receive less emotional support. Women tend to rely on social support and are more likely to elicit and receive emotional assistance to cope. 36 Our results highlight the unique interplay between depression, gender and non-compliance, and the need to identify and treat depression and other mood disturbance in all patients undergoing an AHSCT, and to be especially attuned to unspoken depression and distress in men. Nausea/vomiting intensity (N/V) was another robust predictor of increased non-compliance, consistent with studies examining contributing factors of non-compliance among human immunodeficiency virus patients to medication. 38 Although nausea is often examined within the oncology literature as a source of distress, it has not been widely studied as a potential contributor to non-compliance. The finding in this study deserves further consideration and may indicate a unique impact that N/V has on a patient's well-being and ability to commit to a regimen. Of note, N/V may affect multiple aspects of compliance behavior (for example, diet, ability to exercise, medication adherence) and could have a greater impact on noncompliance as compared with other side effects.
A number of medical factors were not significantly associated with non-compliance, including days from diagnosis to transplant, TBI, length of stay, days of neutropenia, medical comorbidities, admission for complications, side effects other than N/V (for example, fever, diarrhea, pain associated with mucositis) or mortality status at 1 year later. These non-significant findings draw attention to the link between non-compliance and other factors, such as the patients' state of mind and N/V and speak to the need to identify and aggressively treatment these problems. It is also possible that the retrospective research design used in the study lacked the rigor necessary to identify significant relationships between medical factors and non-compliance. Further, it may be that the type of non-compliance is more important than overall levels noncompliance (for example, non-compliance with medications vs lack of exercise).
Non-compliance was also not significantly associated with several sociodemographic variables. The lack of significance for social support is best explained by the high degree of social support (which is required for outpatient transplant), patients' satisfaction with support and that the majority of patients were married or partnered (85%). Similarly, education, which has been associated with compliance in previous research, 39, 40 was not significant in this study, and likely reflects the relatively high level in our sample (median years of education ¼ 15).
In summary, the study findings indicate that noncompliance during outpatient AHSCT is a complex outcome related to several important modifiable factors; namely depression, psychological distress and severe nausea and vomiting. The results speak to the need to expand our conceptualizations of risk factors from strictly medical variables to a broader biopsychosocial model and the importance of assessing patient barriers to compliance.
Study limitations include using a convenient sample from a single transplant center. In addition, the retrospective chart review of compliance and the correlational analyses prevent causal inferences between variables. Future studies should attempt to study non-compliance of AHSCT patients within a longitudinal framework; use a standardized measure of compliance to allow for daily assessment of specific behaviors; and explore other factors that might affect compliance such as the importance of who the message bearer is (for example, physician, nurse, allied health professional, family member) and how it is framed; patients' previous health behaviors, self efficacy to adhere and coping resources. Significant findings could then be used to inform the design of a randomized clinical trial of a behavioral intervention to improve compliance in AHSCT patients.
